Eric Hodgins Appointed as the Chief Information Officer of Precision Medicine Group

Eric Hodgins Takes the Helm as CTO of Precision Medicine Group

Precision Medicine Group has recently appointed Eric Hodgins as its Chief Information and Technology Officer (CTO). With an extensive background of over 30 years in clinical and commercial technologies, Hodgins is set to play a crucial role in steering the company's technology strategy and its assets.

A Visionary Leader in Pharma Services

Hodgins previously held the position of Senior Vice President at IQVIA, where he was instrumental in developing technological solutions that improved the efficiency of clinical trials and enhanced patient engagement. His initiatives not only increased operational efficiency but also ensured compliance with regulatory requirements, highlighting his commitment to advancing healthcare solutions.

Margaret Keegan, the CEO of Precision, remarked, “Eric is a visionary in the field with a deep commitment to advancing patient care and client-oriented solutions.” She emphasized Hodgins' transformative results achieved at one of the world’s largest Contract Research Organizations (CROs), underscoring his capability in enhancing technologies that respond to clients' needs in research and commercialization.

Driving Technological Innovation

Under Hodgins' guidance, Precision aims to further enhance its focus on developing and optimizing transformative technologies across its research and development (R&D) and commercial service sectors. His belief in building client-centric, agile, and innovative solutions aligns perfectly with Precision's mission to create significant impacts for patients suffering from cancer and rare diseases.

Hodgins expressed enthusiasm about his new role, stating, “I look forward to delivering Precision's clients innovative, best-in-class solutions that seamlessly fit into their business.” He highlighted the undeniable impact of technology on clinical development and commercialization in modern healthcare, particularly emphasizing the role that artificial intelligence (AI) and other emerging technologies play in providing actionable insights for biopharmaceutical companies.

A Rich History of Impact in Technology

Before stepping into his pivotal role at Precision Medicine Group, Hodgins founded a clinical technology startup, where he also served as Chief Technology Officer. After successfully selling his company to a major CRO, he dedicated the next 15 years to building the technological infrastructure for one of the largest CROs in the marketplace. More recently, he has managed various technology businesses that concentrated on Patient Engagement and Safety/Regulatory/Quality. His depth of experience encompasses innovation in technology and alignment with business strategy, making him a formidable addition to Precision's leadership team.

His educational background includes a BS in Mechanical Engineering from the University of Texas, Austin, underpinning his technical expertise with a solid foundation in engineering principles.

About Precision Medicine Group

Established in 2012, Precision Medicine Group has positioned itself as a leader in next-generation approaches to drug development and commercialization. With over 3,500 employees and headquartered in Bethesda, Maryland, the company offers a breadth of integrated services, including biomarker intelligence, lab services, a global CRO, and market access consulting. The organization is committed to supporting life sciences innovators in navigating their path to market successfully.

In summary, Eric Hodgins' appointment as CTO marks a strategic step for Precision Medicine Group as it strives to leverage cutting-edge technology to enhance patient care and optimize drug development processes. With his leadership, the company is expected to drive significant advancements in the healthcare technology landscape.